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Mycolic acids are vital components of the cell wall of
the tubercle bacillus Mycobacterium tuberculosis
and are required for viability and virulence. While
mycolic acid biosynthesis is studied extensively,
components involved in mycolate transport remain
unidentified. We investigated the role of large
membrane proteins encoded by mmpL genes in
mycolic acid transport in mycobacteria and the
related corynebacteria. MmpL3 was found to be
essential in mycobacteria and conditional depletion
of MmpL3 in Mycobacterium smegmatis resulted in
loss of cell wall mycolylation, and of the cell wall-
associated glycolipid, trehalose dimycolate. In
parallel, an accumulation of trehalosemonomycolate
(TMM) was observed, suggesting that mycolic acids
were transported as TMM. In contrast to mycobacte-
ria, we found redundancy in the role of two mmpL
genes, in Corynebacterium glutamicum; a complete
loss of trehalose-associated and cell wall bound
corynomycolates was observed in an NCgl0228-
NCgl2769 double mutant, but not in individual single
mutants. Our studies highlight the role of mmpL
genes in mycolic acid metabolism and identify
potential new targets for anti-TB drug development.
INTRODUCTION
Mycolic acids are vital components of the waxy cell wall of
Mycobacterium tuberculosis, the causative agent of tuberculosis
(TB). Synthesized by the concerted and sequential action of
three enzymatic units, fatty acid synthase I (FAS-I), fatty acid
synthase II (FAS-II), and a polyketide synthase (Pks13), these
very long-chain a-alkyl, b-hydroxy fatty acids are essential for
viability and virulence (Bhatt et al., 2005, 2007; Brown et al.,
2007; Dubnau et al., 2000; Glickman et al., 2000; Vilche`ze
et al., 2000). While core mycolate biosynthesis is now well
studied in mycobacteria and in the related Corynebacterium
glutamicum, the processing of newly synthesized mycolic acids498 Chemistry & Biology 19, 498–506, April 20, 2012 ª2012 Elsevierand their subsequent transport for deposition in the cell wall
remains poorly understood. An earlier report of an ABC trans-
porter mutant affected in mycolic acid composition turned out
to be an indirect effect due to altered lipoglycan biosynthesis
(Mishra et al., 2008; Wang et al., 2006). Takayama et al. (2005)
suggested a hypothetical pathway that involves the transfer of
a mature mycolate to an isoprenoid carrier, forming MycPL
(6-O-mycolyl-b-D-mannopyranosyl-mono phospho- heptapre-
nol), and subsequently to trehalose inside the cell to yield treha-
lose monomycolate. TMM is then proposed to be transported by
a yet unknown mechanism outside the cell where it is used as
a substrate by the mycolyltransferase enzymes of the Ag85
complex (Belisle et al., 1997; Puech et al., 2002), to transfer
the mycolate residue to either the arabino-galactan (AG)
complex (wall bound mycolates), or to another TMM (resulting
in formation of TDM). Alternatives to this hypothetical pathway
include intracellular synthesis of TDM prior to transport, or the
flipping of Myc-PL to the outside for subsequent use as
a substrate for extracellular formation of TMM. Apart from the
identification of Myc-PL as a carrier-bound intracellular interme-
diate (Besra et al., 1994), and the mycolyltransferase activity of
the Ag85 proteins (Belisle et al., 1997; Puech et al., 2002), not
much is known about the intracellular processing and subse-
quent transport of mycolic acids.
The genomes ofM. tuberculosisH37Rv and other mycobacte-
ria contain a number of genes encoding proteins that belong to
a family of multidrug resistance pumps termed RND (resistance,
nodulation, and division) proteins (Cole et al., 1998; Domenech
et al., 2005). Designated MmpL (for mycobacterial membrane
protein large), these proteins typically contain 12 transmem-
brane (TM) domains and two non-TM loops. None of the myco-
bacterial MmpLs studied so far appear to play any role in drug
resistance (mmpL7 conferred resistance to isoniazid when over-
expressed inMycobacterium smegmatis but theM. tuberculosis
mmpL7 mutant did not display altered sensitivity to the drug;
Pasca et al., 2005). Instead, many mmpL genes are associated
with clusters involved in the biosynthesis of cell wall-associated
glycolipids like sulfolipids, polyacylated trehalose, glycopeptido-
lipids, lipooligosaccharides, and other complex lipids like phthio-
cerol dimycocerosate (PDIM) (Cole et al., 1998; Converse et al.,
2003; Cox et al., 1999; Domenech et al., 2004, 2005; Rombouts
et al., 2011; Sonde´n et al., 2005). MmpLs are proposed to
function as scaffolds for the biosynthetic machinery, allowingLtd All rights reserved
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Figure 1. Maps of the mmpL3-mmpL11 Region in Different Mycobacteria
Homologous genes are indicated by similar arrows. Arrows with hatched borders indicate genes found exclusively in M. smegmatis, and a pseudogene in
M. leprae is depicted by an arrow with a dotted border.
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Mycolic Acid Transporters in Mycobacterialocalized synthesis of a cell wall associated lipid, pairing with an
ABC transporter (Sonde´n et al., 2005), and in some cases an
MmpS protein (Deshayes et al., 2010), to facilitate transport.
Indeed, a two hybrid screen using the non-TM domains of the
PDIM transporter MmpL7 revealed interactions with enzymes
involved in the final stages of biosynthesis of the phthiocerol
moiety (Jain and Cox, 2005). In some cases, such ‘‘mega
complexes’’ may involve localized ‘‘flipping’’ of a biosynthetic
intermediate for presentation to extracytoplasmic enzymes
involved in the biosynthesis of the lipid, as was observed with
MmpL8 and sulfolipid SL-I (Converse et al., 2003; Domenech
et al., 2004). Thus, it seemed likely that an MmpL protein may
be involved in the translocation of a mycolate-containing glyco-
lipid (TMM, TDM, or Myc-PL) to the outside of the bacterial cell
for subsequent use as a substrate for cell wall mycolylation.
Mycobacterium leprae, which contains a high degree of
‘‘genetic decay’’ but still possesses an intact cell wall containing
mycolic acids, represents a valuable referencewhen considering
candidate genes for essential cell wall-related functions like my-
colic acid metabolism. Homologs of only 5 of 14M. tuberculosis
mmpL genes are present in M. leprae, of which only mmpL3
is predicted to be an essential gene based on studies in
M. tuberculosis (Domenech et al., 2005). Given the essentiality
of mycolic acids for viability of mycobacteria (Bhatt et al.,
2005; Parish et al., 2007; Portevin et al., 2004; Vilche`ze et al.,
2000), it was likely that mmpL3 was involved in mycolate trans-
port in M. tuberculosis. In this study, we have investigated the
role ofmmpL3 in mycolic acid transport by generating and char-
acterizing a conditional mutant of MSMEG0250, the homolog
of mmpL3 in the fast growing Mycobacterium smegmatis. In
parallel, we also compared and contrasted the role of mmpL
genes in Corynebacterium glutamicum, a bacterium that has
a cell wall similar to mycobacteria including the presence of my-
colic acids, called corynomycolic acids (both belong to the
suborder Corynebacterineae). A particular advantage of using
corynebacteria is the ability to generate viable corynomyco-
late-deficient mutants (Gande et al., 2004, 2007; Portevin et al.,
2004, 2005) and our studies demonstrated a functional redun-
dancy of corynomycolate metabolism-associated MmpLs in
this genus.Chemistry & Biology 19,RESULTS
MmpL3 Is an Essential Gene in Mycobacteria
M. tuberculosis mmpL3 (Rv0206c) was first proposed to be an
essential gene by Domenech et al. (2005) on the basis of the
inability to obtain an mmpL3 knockout mutant. While the gene
is not located near any known mycolic acid biosynthesis genes,
the gene cluster surrounding mmpL3 shows a high level of syn-
teny with other mycobacterial species including M. leprae (Fig-
ure 1). This includes the presence of three putative membrane
associated proteins (Figure 1), and a second mmpL gene,
mmpL11, situated downstream of mmpL3. While Domenech
et al. (2005) did not detect any alterations in the lipid profile of
an M. tuberculosis mmpL11 mutant, the strain was attenuated
in the mouse model of infection.
The protein encoded by mmpL3 is predicted to be
a membrane associated protein, and contains 12 TM domains
and two non-TM loops, L1 and L2 of sizes 151 and 142 amino
acids, respectively (Figure 2). We first constructed a knockout
phage designed to delete MSMEG0250, the M. smegmatis
homolog of M. tuberculosis mmpL3, and consistent with find-
ings from previous studies in M. tuberculosis (Domenech
et al., 2005), we were unable to generate a null mutant. Subse-
quently, CESTET, a tool designed to test gene essentiality in
M. smegmatis (Bhatt et al., 2005), was used to obtain a condi-
tional mutant of MSMEG0250. The strain, DMSMEG0250
contained a recombinant, integrated copy of mmpL3 under
the control of the inducible acetamidase promoter, while the
native copy of the gene was deleted and replaced with a
hygromycin resistance cassette. The viability of DMSMEG0250
was dependent on the addition of the inducer acetamide in the
growth medium confirming that MSMEG0250 was an essential
gene (Figure 3).
MmpL3 Is Involved in Mycolic Acid Transport
in Mycobacteria
Recently, spontaneous mutants resistant to BM212 and SQ109,
compounds with anti-TB activities, were shown to contain muta-
tions mapping to mmpL3 (LaRosa et al., 2012; Tahlan et al.,
2012). Furthermore, cells exposed to SQ109 were shown to498–506, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 499
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Figure 2. Predicted Topology ofMmpL3 and
Corynebacterial MmpLs
The TM regions are indicated by cylinders and
are numbered while the two non-TM loops of
MmpL3 are indicated as L1 and L2. The carboxy
and amino termini are indicated by ‘‘C’’ and ‘‘N,’’
respectively. The Mobyle@Pasteur server was
used for topology predictions (http://mobyle.
pasteur.fr/cgi-bin/portal.py#forms::toppred).
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efflux of TMM. To address the putative role of MmpL3 in TMM
efflux, we assessed the effects of depletion of MSMEG0250
on lipid metabolism in the M. smegmatis conditional mutant,
making use of a three stage extraction procedure: (1) petroleum
ether extraction of the cell pellet that does not affect the
integrity of the cells, but extracts the surface-exposed, non-
covalently bound cell wall lipids; (2) extraction of apolar and
polar lipids from the ‘‘petroleum ether stripped’’ pellet; and (3)
extraction of AG-bound mycolic acids from the resultant delipi-
dated cells. Cultures of the DMSMEG0250 conditional mutant
were grown in broth in the presence or absence of acetamide,
labeled with [14C]-acetate at different time points and subjected
to the above three stage extraction procedure. For cultures
grown in the presence of acetamide, TMM was predominantly
found in the apolar lipid extract from cell pellets (Figure 4A).
However, TDM was found in both the petroleum ether extract,
and in the apolar lipid extract from the subsequent cell pellets.
An earlier examination we had conducted of M. smegmatis cell
pellets extracted with consecutive treatments of petroleum
ether indicated that no further TDM was extracted from cells
after the third consecutive extraction. Each petroleum ether
extract of the DMSMEG0250 conditional mutant shown in
Figure 4A represent a pool of five consecutive extractions of500 Chemistry & Biology 19, 498–506, April 20, 2012 ª2012 Elsevier Ltd All rights reservedthe same sample and thus the presence
of TDM in the subsequently processed
cell pellet was not due to insufficient
petroleum ether extraction. The exact
location of these cell-associated TDM
molecules that resist petroleum ether
extraction is unknown, but it is possible
that they represent newly synthesized
TDM that is closer to the inner membrane
and thus inaccessible to petroleum ether
extraction.
In contrast to the cultures of the condi-
tional mutant grown in the presence of
acetamide, [14C]-labeled cultures grown
in the absence of acetamide showed
an increasing amount of TMM in cell
pellets, that was accompanied by
decrease in TDM levels both in the
petroleum ether extracts and in the
apolar fraction from cells (Figure 4A;
Figure S1 available online). Conditional
depletion of MSMEG0250 also resulted
in a decrease in mycolylation of AG
(Figure 4B). The accumulation of TMMin the cells over time following conditional depletion suggested
that loss of MSMEG0250 function affected TMM transport
either directly or indirectly.
RedundantmmpL Functions in Corynebacterium
glutamicum
The cell walls of corynebacteria, which are similar to those of
mycobacteria, contain trehalose monocorynomycolate (TMCM)
and trehalose dicorynomycolate (TDCM), the equivalents of
TMM and TDM, as the outer, noncovalently bounds glycolipids.
As corynomycolic acid biosynthesis is a nonessential process,
it is possible to generate viable mutants of corynebacteria that
do not produce corynomycolates. In a parallel study on the
role of MmpLs in corynomycolate transport in C. glutamicum,
we conducted a BLAST search of the C. glutamicum ATCC
13032 genome, using the amino acid sequences of open reading
frames fromM. tuberculosis mmpL3-mmpL11 region as queries.
The search revealed that there was no corynebacterial equiva-
lent of the mycobacterial mmpL3-mmpL11 cluster. However,
the genome of C. glutamicum does encode four mmpL genes,
NCgl0228, NCgl0559, NCgl0887, and NCgl2769 in distinct
locations on the genome. As TMCM and TDCM are the only
abundant, noncovalently bound outer envelope glycolipids in
C. glutamicum, it seemed likely that one or more of these
Figure 3. Essentiality of MSMEG0250 in M. smegmatis mc2155
Growth of the conditional mutant DMSMEG0250 and parental merodiploid
strain (mc2155::pMV306mmpL3) on Tryptic Soy Agar with or without the
inducer acetamide. Ten microliters of 10-fold serial dilutions of cultures was
spotted on the agar plates and incubated for 5 days at 37C.
A
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Figure 4. Lipid Analysis of the DMSMEG0250 Conditional Mutant
(A) 2D-TLC analysis of [14C]-labeled lipids from the DMSMEG0250 conditional
mutant. Cultures were grown and labeled in tryptic soy broth in the presence or
absence of acetamide. Petroleum ether extracts (Fraction-I) and intracellular
apolar lipids (Fraction-II) were separated on using chloroform:methanol:
water (100:14:0.8) in Direction 1 and chloroform:acetone:methanol:water
(50:60:2.5:3) in Direction 2. Positions of TMM and TDM are indicated by dotted
and solid arrows, respectively.
(B) TLC analysis ofmethyl esters of [14C]-labeled, cell wall boundmycolic acids
(MAMES) separated using petroleum ether:acetone (95:5) as the solvent
system. Methyl esters of the different subclasses of mycolic acids are indi-
cated.
See also Figure S1.
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NCgl0599 was associated with a cluster involved in the biosyn-
thesis of a carotenoid pigment (Krubasik et al., 2001), it was
not considered for further study.
NCgl0228 and NCgl2769 revealed predicted topologies
similar to M. tuberculosis MmpL3 (12 TM domains and two
non-TM loops), while that of NCgl0887 appeared different (Fig-
ure 2). Interestingly, NCgl0887 is situated in a cluster containing
a trehalose corynomycolyl transferase, and NCgl2769 is present
downstream of the corynomycolate condensase gene, pks13.
To probe the role of C. glutamicum mmpLs in corynomycolate
transport, we generated individual in frame deletion mutants of
NCgl0228, NCgl0887, and NCgl2769 in C. glutamicum ATCC
13032. Loss of corynomycolic acids from the cell envelope
results in poor growth rates leading to smaller colonies (Gande
et al., 2004). None of the three mutant strains (DNCgl0228,
DNCgl0887, and DNCgl2769) showed any alterations in colony
size or appearance (Figure 5). To investigate potential functional
redundancies between the three C. glutamicum mmpL genes,
double and triple mutant strains were constructed. While
the colony sizes and appearance of the double mutants,
DNCgl0228-DNCgl0887 and DNCgl0887-DNCgl2769, remained
unaltered (Figure 5), the DNCgl0228-DNCgl2769 mutant formed
smaller colonies and showed ‘‘clumpy’’ growth in broth. A similar
growth defect was observed for the triple mutant DNCgl0228-
DNCgl0887-DNCgl2769 (Figure 5). Thus, while single deletions
ofNCgl0228 orNCgl2769 did not have any effect, the concurrent
loss of NCgl0228 and NCgl2769 severely affected the growth
patterns of the mutant strain, indicating potential alterations in
the cell wall.
NCgl0228 and NCgl2769 Play a Role in Corynomycolate
Metabolism
To determine whether the phenotype observed above for some
of the C. glutamicum mmpL mutants were linked to defects in
corynomycolate transport, petroleum ether extracts of surface-
exposed lipids, and subsequent, remaining total lipids were
extracted from [14C]-acetate-labeled cell pellets. TLC analysisChemistry & Biology 19,showed that the parental strain and most mutant strains
produced TMCMand TDCM, with the latter found predominantly
in the petroleum ether extracts containing surface-exposed
lipids (Figures 6A and 6B). Furthermore, levels of AG-bound
corynomycolic acids for most mutant strains were the same
as the parental, wild-type strain C. glutamicum (Figure 6C).
The two exceptions were the DNCgl0228-DNCgl2769 and498–506, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 501
Figure 5. Growth Characteristics of the C. glutamicum mmpL Mutant Strains
Colonies ofC. glutamicummmpLmutant strains on brain heart infusion agar plates (top panel) and broth cultures of the same in brain heart infusion broth (bottom
panel). The scale bar represents 1 mm.
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Mycolic Acid Transporters in MycobacteriaDNCgl0228-DNCgl0887-DNCgl2769 mutant strains, in which
no TMCMor TDCMwas detected in the petroleum ether extracts
or in the cell pellets (Figures 6A and 6B). Additionally, no AG-
bound corynomycolic acids were observed in the DNCgl0228-
DNCgl2769 and DNCgl0228-DNCgl0887-DNCgl2769 strains
(Figure 6C). The absence of any TMCM, TDCM, and AG-bound
corynomycolates suggested either that there was a complete
cessation of corynomycolic acid biosynthesis in the double
and triple mutants or that corynomycolates were being trans-
ported in an alternate (carrier-bound) form that was used as
substrate for TMCM, TDCM, and AG-bound corynomycolate
synthesis. However, the latter seemed less likely as no interme-
diates were seen to accumulate in the DNCgl0228-DNCgl2769
and DNCgl0228-DNCgl0887-DNCgl2769mutants. These results
also indicated a functional redundancy between NCgl0228 and
NCgl2769 with regards to corynomycolate metabolism. No
additional alterations in lipid profiles were observed in the triple
mutant suggesting that NCgl0887 did not play any apparent
role (Figures 6A–6C). Complementation of the double mutant
with either plasmid-borne NCgl0228 or NCgl2769 restored cory-
nomycolate biosynthesis, though in case of the latter gene, the
complementation was partial (Figures 7A and 7B and Figure S2).
DISCUSSION
Our studies demonstrated that mmpL3 plays a role in mycolic
acid transport; the intracellular accumulation of TMM in the
M. smegmatis MSMEG0250 mutant following conditional
depletion suggested that TMM was the likely carrier for the
mycolic acid moiety. The exported TMM is presumably used
as substrate by the enzymes of the Ag85-complex for mycolyla-502 Chemistry & Biology 19, 498–506, April 20, 2012 ª2012 Elseviertion of the cell wall AG and the formation of cord factor (TDM).
Our findings were complemented by the drug-to-target
approach used by La Rosa et al. (2012) and Tahlan et al.
(2012), with the latter demonstrating that treatment with
a compound that targeted MmpL3 resulted in a phenotype iden-
tical to what we observed with the M. smegmatis conditional
mutant. Additionally, during the review of this manuscript, Grze-
gorzewicz et al. (2012) reported that AU1235, an adamantly urea
inhibitor of M. tuberculosis, also targeted MmpL3. Notably, the
authors showed a decrease in the levels of TDM and AG-bound
mycolates in M. tuberculosis cells treated with AU1235,
and accumulation of TMM in the inner membrane. Additionally,
they were also able to reproduce the effects of AU1235 in
cultures of a M. smegmatis conditional mmpL3 mutant grown
under nonpermissive conditions; a result similar to that obtained
for the DMSMEG0250 mutant described in this study.
MmpL3 may not be solely responsible for transport; in
M.smegmatis; glycopeptidolipid transport requires the concerted
action of an MmpL protein, MmpS4 and a third transmembrane
protein termed Gap (Deshayes et al., 2010; Sonde´n et al., 2005).
The region downstream ofmmpL3 encodes two transmembrane
proteins, Rv0204c andRv0205,whichmay formpart of a complex
involved in the transport of TMM (though the M. leprae homolog
of the latter is annotated as a possible pseudogene). Additionally,
the biosynthetic clusters for PDIM also contain ABC transporters
and thus the role of ABC transporters in mycolate transport
(acting in conjunction with MmpL3) remains a possibility.
A recent study by Tullius et al. (2011) has suggested a role for
the mmpL3-mmpL11 gene cluster in heme transport. The
authors report that they were also able to delete a region of the
M. smegmatis genome that included MSMEG0250. In ourLtd All rights reserved
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Figure 6. Lipid Analysis of the C. glutamicum
mmpL Mutant Strains
(A and B) TLC analysis of [14C]-labeled lipids extracted
from C. glutamicummmpLmutant strains separated using
CHCl3:CH3OH:H2O (60:16:2) as the solvent system. (A)
Petroleum ether extracts, (B) total lipids from petroleum
ether-treated cells.
(C) TLC analysis [14C]-labeled fatty acid methyl esters
(FAMES) and corynomycolic acid methyl esters
(CMAMES) extracted from delipidated cells, using petro-
leum ether:acetone (95:5) as the solvent system. The
pks13 null mutant Dpks13, which does not produce cor-
ynomycolic acids, was used as a control.
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Mycolic Acid Transporters in Mycobacteriastudies, we were unable to generate an individual null mutant of
MSMEG0250 in M. smegmatis mc2155 despite repeated
attempts (also observed for the M. tuberculosis homolog by
Domenech et al., 2005). We were, however, able to demonstrate
the essentiality of MSMEG0250 using CESTET and show that
conditional depletion caused a loss of TDM and of cell wall
(AG) mycolylation, and the intracellular accumulation of TMM.
In contrast to mycobacteria, we observed several differences
in the role of mmpL genes in corynomycolate transport in
C. glutamicum. First, there was no equivalent corynebacterial
cluster exhibiting synteny with mycobacterial mmpL3-mmpL11
region. Instead, a functional redundancy was observed between
NCgl0228 and NCgl2769 located in two distinct regions of the
C. glutamicum genome. Individual deletion of either of these
mmpL genes did not have any effect, but simultaneous deletion
of both genes led to complete loss of TMCM, TDCM and
AG-bound corynomycolates. This was in contrast to the
M. smegmatis conditional mutant in which conditional depletion
of MSMEG0250 led to loss of TDM and AG mycolylation, but
intracellular accumulation of TMM. As mentioned above, while
this result raised the possibility that corynomycolate transport
may involve a carrier other than TMCM, this seemed highly
unlikely, given the absence of any accumulating intermediate
in the C. glutamicum DNCgl0228-DNCgl2769 and DNCgl0228-
DNCgl0887-DNCgl2769 mutant strains. Instead, variations inChemistry & Biology 19, 498–506, April 20the phenotypes of the mycobacterial and cory-
nebacterial mutants may be a reflection of
fundamental differences in mycolic acid biosyn-
thesis in the two genera. Mycobacterial mycolic
acid biosynthesis requires several components
including a multidomain type-I fatty acid syn-
thase (FAS), a multienzyme type-II FAS
complex, modifying enzymes and Pks13 (Rad-
macher et al., 2005; Takayama et al., 2005). Cor-
ynomycolate biosynthesis on the other hand
requires two type-I FASs and Pks13. MmpLs
are also envisaged to act as scaffolds for the
localized biosynthesis on the cell membrane,
facilitating concerted biosynthesis and trans-
port. In mycobacteria, due to the far larger
number of components involved, mycolate bio-
synthesis may be delinked from transport.
Instead, MmpL3 could form a complex with
other proteins involved in TMM transport. Asa result, loss of MmpL3 would not cause a direct cessation of
mycolate biosynthesis. In contrast, in C. glutamicum, where
corynomycolate biosynthesis requires fewer enzymatic compo-
nents, late-stage enzymes such as Pks13 may depend on inter-
action with an MmpL-complex to ensure that corynomycolate
biosynthesis is coupled to transport. Thus, a concurrent loss of
NCgl0228 and NCgl2769 would lead to not just the loss of
a transport complex, but also disrupt the late stages of coryno-
mycolate biosynthesis. The identification ofmmpL3 as an essen-
tial membrane protein-encoding gene involved in mycolate
transport opens up new avenues for targeting this vital and
under-exploited mycobacterial pathway for developing new
anti-TB drugs, an opportunity highlighted by the identification
of MmpL3 as the target of three drugs (La Rosa et al., 2012; Tah-
lan et al., 2012; Grzegorzewicz et al., 2012).
SIGNIFICANCE
One of the greatest challenges for combating TB is the
recent rise of multidrug-resistant (MDR) and extensively
drug-resistant (XDR) strains of M. tuberculosis. Despite
being critical for viability and virulence (and the target of
the hallmark anti-TB drug isoniazid), pathways involved in
the biosynthesis of mycolic acids remain poorly exploited
as drug targets. Additionally, components involved in the, 2012 ª2012 Elsevier Ltd All rights reserved 503
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Figure 7. Complementation of the C. glutamicum mmpL Double-
Mutant Strain
TLC analysis of (A) total lipids and (B) AG-bound corynomycolates from com-
plemented C. glutamicum DNCgl0228-DNCgl2769 double-mutant strains.
See also Figure S2.
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Mycolic Acid Transporters in Mycobacteriapostbiosynthesis processing and transport ofmycolates are
not known and remain an untapped source of potential drug
targets. This study identifies a gene (mmpL3) involved inmy-
colic acid transport in mycobacteria. Furthermore, the
results obtained from the C. glutamicum mutants indicate
that transport processes may be coordinated with biosyn-
thesis via protein-protein interactions with MmpLs acting
as molecular scaffolds, thus opening up new avenues for
studying novel transport mechanisms for mycobacterial
lipids.
EXPERIMENTAL PROCEDURES
Generation and Characterization of a M. smegmatis MSMEG0250
Conditional Mutant
The M. smegmatis conditional mutant DMSMEG0250 was generated using
CESTET (Bhatt et al., 2005). Briefly, a merodiploid was first generated by
introducing an integrating vector pMV306-mmpL3 by electroporation into504 Chemistry & Biology 19, 498–506, April 20, 2012 ª2012 ElsevierM. smegmatis mc2155 (Snapper et al., 1990) (pMV306-mmpl3 consists
of mmpL3 cloned downstream of the acetamidase promoter in the inte-
grative vector pMV306 (Stover et al., 1991)). The merodiploid strain
mc2155::pMV306mmpl3 was then subjected to specialized transduction as
previously described (Bardarov et al., 2002; Larsen et al., 2007) using
phDMSMEG0250, a temperature sensitive, recombinant phage designed to
replace MSMEG0250 with a hygromycin resistance marker. Transductants
were selected at the nonpermissive temperature of 37C on selective plates
containing 150 mg/ml hygromycin. After confirmation of gene replacement
by Southern blot, one such transductant was named DMSMEG0250 and
was selected for further analysis. Conditional depletion of MSMEG0250 in
DMSMEG0250 to visualize [14C]-labeled mycolic acids and other lipids was
carried out as described before (Bhatt et al., 2005).
Generation and Characterization of C. glutamicum mmpL Mutant
Strains
To generate specific deletions of NCgl0228, NCgl0887, or NCgl2769 in the
chromosome of C. glutamicum, the nonreplicable vector pK19mobsacB was
used (Scha¨fer et al., 1994), containing inserts synthesized by GeneArt. The
inserts contained 12 nucleotides (nt) of the 30 end of the respective gene
together with 300 bp genomic upstream sequences, and 36 nt of the 50 end
together with 300 bp genomic downstream sequences. The respective vector
constructed was used to transformC. glutamicum ATCC 13032 to kanamycin-
resistance (Kanr) indicating chromosomal integration. Sucrose-resistant (Sucr)
clones were selected in a second round of positive selection, indicating loss
of the vector-encoded sacB function. After the second recombination
event about half of the recombinants contained the desired deletion, as verified
by PCR, and one strain each was termed C. glutamicum DNCgl0228,
C. glutamicum DNCgl0887, and C. glutamicum DNCgl2769, respectively. The
double-mutant C. glutamicum DNCgl0887DNCgl2769 was generated using
C. glutamicum DNCgl0887 and using the appropriate pK19mobsacB
construct. In-frame deletion of NCgl0228 in a single- or double-mutant back-
ground was not possible despite repeated attempts. As an alternative, we
used pK19mobsacBNCgl0228, containing an internal fragment of NCgl0228
amplified by primer pairs 50-CATAGAATTCGTGGCTGTGCTCATTGCGTT
GAC-30 and 50-GTACGTCGACCTCTGCCATCAAATCAGCCGACTG-30. This
vector was used to disrupt NCgl0228 in C. glutamicum DNCgl0887, in
C. glutamicum DNCgl2769 and in C. glutamicum DNCgl0887-DNCgl2769 to
generate the double-mutants C. glutamicum DNCgl0228-DNCgl0887 and
DNCgl0228-DNCgl2769, and the triple mutant C. glutamicum DNCgl0228-
DNCgl0887-DNCgl2769. Growth of all mutants was characterized on the
complex medium brain heart infusion broth at 30C, with 25 mgml-1 kanamycin
whenappropriate. Extraction of [14C]-labeled of lipids and corynomycolic acids
from all strains was done as described previously (Gande et al., 2004, 2007).
Complementation of C. glutamicum DNCgl0228-DNCgl2769
NCgl0228 was amplified using primer pairs F0228 (50-CTCATTTGTCGAC
AAGGAGATATAGGTGGCGAAATTGCTATTCAGG-30) and R0228 (50-GGT
GGGATCCCTAACGTGCAGCCTGCTTCTCC-30 ); and NCgl2769 using the
primer pair F2769 (50-ACAATTGTCGACAAGGAGATATAGGTGTTTTCTAAAT
GGGGCCAC-30) and R2769 (50-TCCTCGCGGATCCTTAATCTAGATCCTCA
AGCCTGC-30 ), using C. glutamicum ATCC 13032 chromosomal DNA as
template. PCR products were cloned in pVWEx2 (Eggeling and Bott, 2005)
to yield pVWEx2-NCgl0228 and pVWEx2-NCgl2769, respectively. The inserts
in the plasmids were verified by sequencing, and subsequently used to
transform C. glutamicum DNCgl0228DNCgl0887 to tetracycline resistance
(5 mg ml-1) using transformation protocols described by Eggeling and Bott
(2005).
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.chembiol.2012.03.006.
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